Giorgia Guglielmi

Gut microbiota transplants ease fibromyalgia symptoms in mice and people

Altered gut bacteria may contribute to fibromyalgia and modifying the gut microbiota could offer a promising approach to reduce symptoms of the condition.

Early-life diet can shape the developing infant gut microbiota

The gut microbiota evolves throughout early life, especially during key transitions phases such as weaning.

Antibiotics can weaken vaccine response by disrupting gut bacteria

A healthy, diverse gut microbiota is important for mounting strong and lasting immune responses to vaccination.

Diet shapes gut microbiota to protect mice against C. difficile 

A recent study highlights the potential for dietary interventions in treating C. difficile infection and inflammatory conditions such as inflammatory bowel disease.

Study uncovers new links between gut microbes and multiple sclerosis

Modifying the microbiota could influence multiple sclerosis progression and provide new therapeutic targets.

Gut bacteria from elite athletes boost metabolism in mice

Gut microbes adapt to exercise demands, favoring energy production over bacterial diversity.

How C. difficile uses unique enzyme to survive in the gut

Targeting TudS could be a potential therapeutic approach for treating C. difficile infections.

Distinct Fusobacterium nucleatum populations linked to colorectal cancer

Each Fusobacterium nucleatum population has unique traits and distribution patterns across body sites and conditions such as colorectal cancer and Crohn’s disease.

Gut microbiota-derived bile acids linked to immune issues in multiple sclerosis

Gut microbiota-produced bile acids can be used as therapeutic targets for multiple sclerosis.

Gut bacteria linked to worsening infections in lung disease

Targeting E. lenta or boosting neutrophil function may lead to new treatment strategies for bronchiectasis and related lung diseases.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top